Skip to content

Comparative clinical study of Shigru and Madhushigru kandatwaka in sandhigatavata

A Comparative pharmacotherapeutic study on Shigru kandatwaka (Moringa oleifera Lam.) and Madhushigru kandatwaka (Moringa concanensis Nimmo.) in Sandhigatavata - A

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072906
Enrollment
30
Registered
2024-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M150- Primary generalized (osteo)arthritis

Interventions

None listed

Sponsors

Govrnment Ayurved Hospital vadodara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical sign and symptoms of Sandhigatavata.

Exclusion criteria

Exclusion criteria: Patient having any anatomical deformity. Patient below 40 years and above 70 years. Patient having any cardiac disease , Life threatening disease, Psoariatic arthritis, Rheumatoid arthritis, Gout, Skin disease, SLE, Another musculoskeletal disorders. Local and systemic infections like HIV, STD.

Design outcomes

Primary

MeasureTime frame
Sandhishoola, Prasarana ankuchane vedana.Timepoint: 4 weeks

Secondary

MeasureTime frame
Sandhishotha, Sandhisphutana, Vatapurnadrutisparsha, Sparshasahyata.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Hemalkumar Dodiya

Government Ayurved hospital Vadodara

snghsmn@gmail.com9510172204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026